Envista Holdings Co. (NYSE:NVST – Get Free Report) has earned an average recommendation of “Hold” from the fourteen research firms that are presently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, nine have assigned a hold recommendation and three have assigned a buy recommendation to the company. The average 12 month target price among analysts that have covered the stock in the last year is $20.21.
Several equities analysts recently issued reports on NVST shares. Leerink Partnrs upgraded Envista from a “strong sell” rating to a “hold” rating in a research note on Thursday, October 31st. Wells Fargo & Company lifted their target price on shares of Envista from $20.00 to $21.00 and gave the company an “equal weight” rating in a research note on Thursday, February 6th. Mizuho started coverage on shares of Envista in a report on Wednesday, December 4th. They set an “underperform” rating and a $20.00 price objective on the stock. Needham & Company LLC restated a “hold” rating on shares of Envista in a research report on Thursday, February 6th. Finally, Jefferies Financial Group boosted their target price on Envista from $20.00 to $22.00 and gave the stock a “hold” rating in a research report on Thursday, January 23rd.
Check Out Our Latest Analysis on NVST
Institutional Trading of Envista
Envista Price Performance
NYSE NVST opened at $21.59 on Tuesday. Envista has a 1 year low of $15.15 and a 1 year high of $23.06. The company has a current ratio of 2.04, a quick ratio of 1.77 and a debt-to-equity ratio of 0.44. The company has a market cap of $3.71 billion, a PE ratio of -3.33, a PEG ratio of 2.06 and a beta of 1.34. The stock’s 50-day moving average price is $19.99 and its two-hundred day moving average price is $19.39.
Envista (NYSE:NVST – Get Free Report) last issued its earnings results on Wednesday, February 5th. The company reported $0.24 EPS for the quarter, beating analysts’ consensus estimates of $0.23 by $0.01. Envista had a positive return on equity of 3.86% and a negative net margin of 44.56%. On average, analysts predict that Envista will post 1.06 EPS for the current year.
About Envista
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Featured Articles
- Five stocks we like better than Envista
- The How and Why of Investing in Gold Stocks
- Airbnb’s Earnings: Sky High Results, Grounded Guidance?
- What is the Dow Jones Industrial Average (DJIA)?
- Kyndryl Soars on AI, Cybersecurity Growth—What’s Next?
- Differences Between Momentum Investing and Long Term Investing
- Conflicting Signals: Tempus AI’s Stock Market Rally
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.